[
    {
      "drug": "Olipudase Alfa (Genetical Recombination)",
      "indication": "Acid Sphingomyelinase Deficiency",
      "company": "Sanofi"
    },
    {
      "drug": "Aducanumab",
      "indication": "Treatment and Prevention of Alzheimer's Disease",
      "company": "Biogen"
    },
    {
      "drug": "DS-5141b",
      "indication": "Duchenne Muscular Dystrophy (with a mutation amenable to exon 45 skipping)",
      "company": "Daiichi Sankyo"
    },
    {
      "drug": "SPM-011",
      "indication": "Recurrent Malignant Glioma, unresectable local recurrent head and neck cancer, and advanced non-squamous cell carcinoma",
      "company": "Stella Pharma"
    },
    {
      "drug": "Viltolarsen",
      "indication": "New drug with a new indication",
      "company": "NS Pharma"
    },
    {
      "drug": "Baloxavir Marboxi",
      "indication": "New drug with a new indication",
      "company": "Shionogi"
    },
    {
      "drug": "Gilteritinib Fumarat",
      "indication": "New drug with a new indication",
      "company": "Astellas Pharma"
    },
    {
      "drug": "Borofalan",
      "indication": "New drug with a new indication",
      "company": "Stella Pharma"
    },
    {
      "drug": "Tepotinib Hydrochloride Hydrate",
      "indication": "New drug with a new indication",
      "company": "Merck KGaA"
    },
    {
      "drug": "Entrectinib",
      "indication": "New drug with a new indication",
      "company": "Roche"
    },
    {
      "drug": "Tafamidis Meglumine",
      "indication": "New indication/dosage",
      "company": "Pfizer"
    },
    {
      "drug": "Sirolimus",
      "indication": "New administration route",
      "company": "Pfizer"
    },
    {
      "drug": "Pembrolizumab",
      "indication": "Gastric cancer",
      "company": "Merck & Co."
    },
    {
      "drug": "RTA402",
      "indication": "Diabetic kidney disease",
      "company": "Reata Pharmaceuticals"
    },
    {
      "drug": "JR-141",
      "indication": "Mucopolysaccharidosis Type II (Hunter syndrome)",
      "company": "JCR Pharmaceuticals"
    },
    {
      "drug": "MSC2156119J",
      "indication": "Advanced non-small-cell lung cancers with MET exon 14 skipping mutations",
      "company": "Merck KGaA"
    }
  ]